Mark H. Pollack, M.D. | Psychiatrist.com

Original Research

The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study

November 15, 2005

Mark H. Pollack, Peter P. Roy-Byrne, Michael Van Ameringen, et al

Article

Comorbid Anxiety and Depression.

November 15, 2005

Mark H. Pollack

Original Research

Complicated Grief and Its Correlates in Patients With Bipolar Disorder

September 15, 2005

Naomi M. Simon, Mark H. Pollack, Diana Fischmann, et al

Original Research

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

June 15, 2005

Roger D. Weiss, Michael J. Ostacher, Michael W. Otto, et al

Article

The Pharmacotherapy of Panic Disorder

April 15, 2005

Mark H. Pollack

Article

Benzodiazepines in Clinical Practice: Consideration of Their Long-Term Use and Alternative Agents

February 15, 2005

Julie C. Stevens, Mark H. Pollack

Article

Benzodiazepines in Clinical Practice: Consideration of Their Long-Term Use and Alternative Agents

February 15, 2005

Julie C. Stevens, Mark H. Pollack

Academic Highlights

Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders

February 15, 2005

Jerrold F. Rosenbaum, Charles P. O' Brien, Michael W. Otto, et al

Academic Highlights

Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion.

November 1, 2004

Jerrold F. Rosenbaum, Charles P. O' Brien, Michael W. Otto, et al

Original Research

An Open-Label Study of Levetiracetam for the Treatment of Social Anxiety Disorder

September 1, 2004

Naomi M. Simon, John J. Worthington, Alicia C. Doyle, et al

Article

Long-Term Management of Panic Disorder

March 1, 2004

Alicia Doyle, Mark H. Pollack

Article

Long-Term Management of Panic Disorder

March 1, 2004

Alicia Doyle, Mark H. Pollack

« 1 2 3 4 »